搜索临床试验以:西妥昔单抗联合卡铂/吉西他滨
总计486个结果
-
G1 Therapeutics, Inc.主动,不招人乳腺癌 | TNBC - 三阴性乳腺癌美国, 西班牙, 中国, 法国, 澳大利亚, 乔治亚州, 波兰, 保加利亚, 摩尔多瓦共和国, 俄罗斯联邦, 乌克兰
-
Compugen Ltd招聘中多发性骨髓瘤 | 卵巢癌 | 肺癌 | 晚期癌症 | 结肠癌 | 浆细胞肿瘤 | HNSCC | 微卫星稳定性结直肠癌 | MSS-CRC校验码美国
-
Dalian Medical University尚未招聘
-
Medtronic Cardiac Rhythm and Heart Failure完全的
-
University of ArizonaUniversity of Colorado, Denver未知
-
Jiangsu HengRui Medicine Co., Ltd.招聘中先前接受过曲妥珠单抗和紫杉烷治疗的 HER2 阳性、不可切除和/或转移性乳腺癌受试者中国
-
The Affiliated Hospital of Qingdao University完全的
-
Southern Europe New Drug OrganizationNovartis; Schering-Plough未知
-
PharmAbcineMerck Sharp & Dohme LLC; Novotech (Australia) Pty Limited尚未招聘
-
Fondazione del Piemonte per l'Oncologia完全的
-
Aga Khan UniversityZeenat Qureshi Stroke Institute招聘中
-
Nordic Lymphoma GroupAstraZeneca主动,不招人
-
Heidelberg Pharma AGUnited States Department of Defense完全的
-
Santen Inc.MacuSight, Inc.终止
-
IO BiotechMerck Sharp & Dohme LLC; Theradex; Almac; NeoGenomics招聘中
-
Pieris Pharmaceuticals, Inc.完全的
-
First Affiliated Hospital of Zhejiang UniversityXiangya Hospital of Central South University; Second Affiliated Hospital, School of Medicine... 和其他合作者招聘中
-
Sun Yat-sen UniversityJiangsu HengRui Medicine Co., Ltd.招聘中
-
Lytix Biopharma ASLaboratory Corporation of America; OWL主动,不招人
-
Celleron Therapeutics Ltd.未知
-
St. Petersburg State Pavlov Medical University完全的
-
Memorial Sloan Kettering Cancer CenterWashington University School of Medicine; University of California, Los Angeles; Northwestern... 和其他合作者终止肉瘤 | 平滑肌肉瘤 | 恶性周围神经鞘瘤 | 恶性纤维 | 组织细胞瘤/未分化多形性肉瘤美国
-
University of CologneThe Clinical Trials Centre Cologne; ESCRS (European Society of Cataract and Refractive Surgeons)尚未招聘
-
Yonsei University撤销
-
Bristol-Myers Squibb撤销
-
University of UtahRepare Therapeutics招聘中